| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $275.5M | $326.5M | $343.4M |
| YoY Revenue Growth % | -15.6% | -4.9% | — |
| Gross Profit | $7.6M | $41.7M | — |
| Gross Margin % | 2.8% | 12.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$333.6M | -$156.1M | -$341.9M |
| Operating Margin % | -80.0% | -47.8% | -80.0% |
| Net Income (GAAP) | $219.0M | -$160.3M | -$338.1M |
| EBITDA (Normalized) | -$323.8M | -$147.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$144.9M | -$98.8M | -$107.8M |
| Capital Expenditures (CapEx) | $12.3M | $11.0M | — |
| Free Cash Flow (FCF) | -$157.2M | -$109.8M | -$107.8M |
| FCF Margin % | -57.1% | -33.6% | -31.4% |
| Return on Invested Capital (ROIC %) | -45.0% | -30.2% | — |
| Cash & Short-Term Equivalents | $203.9M | $131.9M | — |
| Total Debt (Short + Long Term) | $415.7M | $1.14B | — |
| Total Stockholders' Equity | -$997.0K | -$601.2M | — |